About the Global Fund

The Global Fund to Fight AIDS, Tuberculosis and Malaria (“the Global Fund”) was established in 2002 as an innovative, multi-billion-dollar international financing institution. It aimed to help the fight against these three diseases by dramatically increasing the amount of funding and directing money to areas of greatest need. The Global Fund is a partnership between governments, development agencies, civil society organizations, the private sector (including businesses and foundations), and communities.

The Global Fund is a financing institution, not an implementing entity and works as a partnership and achieves success by supporting implementer governments, affected communities and other in-country stakeholders to have the tools that they themselves determine are needed to fight the three diseases. The Global Fund 2023 – 2028 strategy’s mission is to attract, leverage and invest additional resources to end the epidemics of HIV, tuberculosis and malaria, reduce health inequities and support attainment of the Sustainable Development Goals.

The Global Fund raises funds in three-year cycles known as Replenishments. Funding is allocated to eligible countries, which use inclusive consultations called ‘country dialogues’ to develop funding requests through Country Coordinating Mechanisms (CCMs). These requests are reviewed by the Technical Review Panel for alignment with technical guidance. Once approved, the funding request is turned into grants, prepared with a Principal Recipient. The Grant Approvals Committee reviews the final grants before Board approval and disbursement. Effective implementation and monitoring are crucial, involving ongoing reviews to address issues and optimize performance. For more details, visit the Global Fund Funding Cycle page.